491 related articles for article (PubMed ID: 29154015)
1. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.
Ronald J; Wang Q; Choi SS; Suhocki PV; Hall MD; Smith TP; Kim CY
Diagn Interv Imaging; 2018 Mar; 99(3):163-168. PubMed ID: 29154015
[TBL] [Abstract][Full Text] [Related]
2. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Do Not Predict Survival After Transjugular Intrahepatic Portosystemic Shunt Creation.
Khabbaz RC; Lokken RP; Chen YF; Lipnik AJ; Bui JT; Ray CE; Gaba RC
Cardiovasc Intervent Radiol; 2018 Jul; 41(7):1029-1034. PubMed ID: 29516241
[TBL] [Abstract][Full Text] [Related]
3. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation.
Gaba RC; Couture PM; Bui JT; Knuttinen MG; Walzer NM; Kallwitz ER; Berkes JL; Cotler SJ
J Vasc Interv Radiol; 2013 Mar; 24(3):411-20, 420.e1-4; quiz 421. PubMed ID: 23312989
[TBL] [Abstract][Full Text] [Related]
4. Different scoring systems in predicting survival in Chinese patients with liver cirrhosis undergoing transjugular intrahepatic portosystemic shunt.
Zhang F; Zhuge Y; Zou X; Zhang M; Peng C; Li Z; Wang T
Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):853-60. PubMed ID: 24915489
[TBL] [Abstract][Full Text] [Related]
5. Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts.
Shoreibah MG; Mahmoud K; Aboueldahab NA; Vande Lune P; Massoud M; Bae S; El Khudari H; Gunn AJ; Abdel Aal AK
J Vasc Interv Radiol; 2019 Feb; 30(2):154-161. PubMed ID: 30717946
[TBL] [Abstract][Full Text] [Related]
6. Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question.
Pitton MB; Zimmermann T; Mildenberger P; Weinmann A; Kloeckner R; Düber C; Mittler J; Hoppe-Lotichius M; Otto G
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e214-e222. PubMed ID: 33230020
[TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis.
Dhanasekaran R; West JK; Gonzales PC; Subramanian R; Parekh S; Spivey JR; Martin LG; Kim HS
Am J Gastroenterol; 2010 Mar; 105(3):635-41. PubMed ID: 19904245
[TBL] [Abstract][Full Text] [Related]
8. No Increased Mortality After TIPS Compared with Serial Large Volume Paracenteses in Patients with Higher Model for End-Stage Liver Disease Score and Refractory Ascites.
Ronald J; Rao R; Choi SS; Kappus M; Martin JG; Sag AA; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY
Cardiovasc Intervent Radiol; 2019 May; 42(5):720-728. PubMed ID: 30603968
[TBL] [Abstract][Full Text] [Related]
9. Early Liver Failure after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis with Model for End-Stage Liver Disease Score of 12 or Less: Incidence, Outcome, and Prognostic Factors.
Luca A; Miraglia R; Maruzzelli L; D'Amico M; Tuzzolino F
Radiology; 2016 Aug; 280(2):622-9. PubMed ID: 26982564
[TBL] [Abstract][Full Text] [Related]
10. Older patient age may predict early mortality after transjugular intrahepatic portosystemic shunt creation in individuals at intermediate risk.
Parvinian A; Shah KD; Couture PM; Minocha J; Knuttinen MG; Bui JT; Gaba RC
J Vasc Interv Radiol; 2013 Jul; 24(7):941-6. PubMed ID: 23707226
[TBL] [Abstract][Full Text] [Related]
11. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
[TBL] [Abstract][Full Text] [Related]
12. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score.
Ferral H; Gamboa P; Postoak DW; Albernaz VS; Young CR; Speeg KV; McMahan CA
Radiology; 2004 Apr; 231(1):231-6. PubMed ID: 14990811
[TBL] [Abstract][Full Text] [Related]
13. Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis.
Wang J; Zhang Z; Yan X; Li M; Xia J; Liu Y; Chen Y; Jia B; Zhu L; Zhu C; Huang R; Wu C
Dig Liver Dis; 2019 Aug; 51(8):1172-1178. PubMed ID: 30765220
[TBL] [Abstract][Full Text] [Related]
14. Performance of artificial intelligence for prognostic prediction with the albumin-bilirubin and platelet-albumin-bilirubin for cirrhotic patients with acute variceal bleeding undergoing early transjugular intrahepatic portosystemic shunt.
Zhong BY; Tang HH; Wang WS; Shen J; Zhang S; Li WC; Yin Y; Yang J; Liu F; Ni CF; Zhao JB; Zhu XL
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e153-e160. PubMed ID: 33177378
[TBL] [Abstract][Full Text] [Related]
15. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study.
Zou D; Qi X; Zhu C; Ning Z; Hou F; Zhao J; Peng Y; Li J; Deng H; Guo X
Turk J Gastroenterol; 2016 Mar; 27(2):180-6. PubMed ID: 27015623
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of the CLIF-C AD Score in Patients With Implantation of Transjugular Intrahepatic Portosystemic Shunt.
Sturm L; Praktiknjo M; Bettinger D; Huber JP; Volkwein L; Schmidt A; Kaeser R; Chang J; Jansen C; Meyer C; Thomas D; Thimme R; Trebicka J; Schultheiß M
Hepatol Commun; 2021 Apr; 5(4):650-660. PubMed ID: 33860123
[TBL] [Abstract][Full Text] [Related]
17. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
18. Impact of transjugular intrahepatic portosystemic shunt creation on intermediate-term model for end-stage liver disease score progression.
Casadaban LC; Gabra MG; Parvinian A; Minocha J; Knuttinen MG; Bui JT; Gaba RC
Transplant Proc; 2014 Jun; 46(5):1384-8. PubMed ID: 24935301
[TBL] [Abstract][Full Text] [Related]
19. MELD-Na as a prognostic indicator of 30- and 90-day mortality in patients with end-stage liver disease after creation of transjugular intrahepatic portosystemic shunt.
Ahmed R; Santhanam P; Rayyan Y
Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1226-7. PubMed ID: 26111072
[TBL] [Abstract][Full Text] [Related]
20. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
Bettinger D; Sturm L; Pfaff L; Hahn F; Kloeckner R; Volkwein L; Praktiknjo M; Lv Y; Han G; Huber JP; Boettler T; Reincke M; Klinger C; Caca K; Heinzow H; Seifert LL; Weiss KH; Rupp C; Piecha F; Kluwe J; Zipprich A; Luxenburger H; Neumann-Haefelin C; Schmidt A; Jansen C; Meyer C; Uschner FE; Brol MJ; Trebicka J; Rössle M; Thimme R; Schultheiss M
J Hepatol; 2021 Jun; 74(6):1362-1372. PubMed ID: 33508376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
